Fate Therapeutics, Inc.
US ˙ NasdaqGM ˙ US31189P1021

SecurityFATE / Fate Therapeutics, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership5,054 shares
Latest Disclosed Value $ 6,064
Citigroup Inc reports 81.59% decrease in ownership of FATE / Fate Therapeutics, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 5,054 shares of Fate Therapeutics, Inc. (US:FATE) valued at $6,065 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 27,459 shares of Fate Therapeutics, Inc.. This represents a change in shares of -81.59% during the quarter. The current value of the position is $11,220 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F FATE THERAPEUTICS COM 31189P102 5,054 -22,405 -81.59 6 -76.92 0.0000
2026-02-13 2025-12-31 13F FATE THERAPEUTICS COM 31189P102 27,459 16,885 159.68 27 100.00 0.0000
2025-11-10 2025-09-30 13F FATE THERAPEUTICS COM 31189P102 10,574 -1,893,164 -99.44 13 -99.39 0.0000
2025-08-11 2025-06-30 13F FATE THERAPEUTICS COM 31189P102 1,903,738 -33,395 -1.72 2,132 39.35 0.0010
2025-05-12 2025-03-31 13F FATE THERAPEUTICS COM 31189P102 1,937,133 1,155,244 147.75 1,531 18.60 0.0008
2025-02-12 2024-12-31 13F FATE THERAPEUTICS COM 31189P102 781,889 707,684 953.69 1,290 398.07 0.0008
2024-11-12 2024-09-30 13F FATE THERAPEUTICS COM 31189P102 74,205 26,336 55.02 260 64.97 0.0002
2024-08-12 2024-06-30 13F FATE THERAPEUTICS COM 31189P102 47,869 -575,189 -92.32 157 -96.57 0.0001
2024-05-10 2024-03-31 13F FATE THERAPEUTICS COM 31189P102 623,058 -220,904 -26.17 4,573 44.90 0.0030
2024-02-09 2023-12-31 13F FATE THERAPEUTICS COM 31189P102 843,962 835,245 9,581.79 3,156 17,433.33 0.0022
2023-12-06 2023-09-30 13F/A-1 FATE THERAPEUTICS COM 31189P102 8,717 -1,066,932 -99.19 18 -99.65 0.0000
2023-11-09 2023-09-30 13F FATE THERAPEUTICS COM 31189P102 8,717 -1,066,932 18 0.0000
2023-08-10 2023-06-30 13F FATE THERAPEUTICS COM 31189P102 1,075,649 -49,259 -4.38 5,120 -20.14 0.0034
2023-05-11 2023-03-31 13F FATE THERAPEUTICS COM 31189P102 1,124,908 929,215 474.83 6,412 224.77 0.0045
2023-02-09 2022-12-31 13F FATE THERAPEUTICS COM 31189P102 195,693 -33,203 -14.51 1,975 -61.52 0.0016
2022-11-10 2022-09-30 13F FATE THERAPEUTICS COM 31189P102 228,896 25,726 12.66 5,130 1.89 0.0037
2022-08-10 2022-06-30 13F FATE THERAPEUTICS COM 31189P102 203,170 168,833 491.69 5,035 278.29 0.0037
2022-05-12 2022-03-31 13F FATE THERAPEUTICS COM 31189P102 34,337 -72,341 -67.81 1,331 -78.68 0.0008
2022-02-10 2021-12-31 13F FATE THERAPEUTICS COM 31189P102 106,678 -62,844 -37.07 6,242 -37.88 0.0033
2021-11-10 2021-09-30 13F FATE THERAPEUTICS COM 31189P102 169,522 107,772 174.53 10,048 87.50 0.0059
2021-08-10 2021-06-30 13F FATE THERAPEUTICS COM 31189P102 61,750 6,085 10.93 5,359 16.78 0.0032
2021-05-13 2021-03-31 13F FATE THERAPEUTICS COM 31189P102 55,665 35,241 172.55 4,589 147.12 0.0030
2021-02-11 2020-12-31 13F FATE THERAPEUTICS COM 31189P102 20,424 12,026 143.20 1,857 452.68 0.0011
2020-11-12 2020-09-30 13F FATE THERAPEUTICS COM 31189P102 8,398 -205,346 -96.07 336 -95.42 0.0002
2020-08-12 2020-06-30 13F FATE THERAPEUTICS COM 31189P102 213,744 160,370 300.46 7,334 518.90 0.0057
2020-05-12 2020-03-31 13F FATE THERAPEUTICS COM 31189P102 53,374 27,799 108.70 1,185 136.53 0.0011
2020-02-12 2019-12-31 13F FATE THERAPEUTICS COM 31189P102 25,575 -62,110 -70.83 501 -63.19 0.0004
2019-11-08 2019-09-30 13F FATE THERAPEUTICS COM 31189P102 87,685 46,872 114.85 1,361 64.37 0.0011
2019-08-12 2019-06-30 13F FATE THERAPEUTICS COM 31189P102 40,813 23,483 135.50 828 172.37 0.0007
2019-05-13 2019-03-31 13F FATE THERAPEUTICS COM 31189P102 17,330 -53,611 -75.57 304 -66.59 0.0003
2019-02-12 2018-12-31 13F FATE THERAPEUTICS COM 31189P102 70,941 -5,477 -7.17 910 -26.91 0.0009
2018-11-13 2018-09-30 13F FATE THERAPEUTICS COM 31189P102 76,418 24,694 47.74 1,245 112.10 0.0011
2018-08-10 2018-06-30 13F FATE THERAPEUTICS COM 31189P102 51,724 41,426 402.27 587 487.00 0.0005
2018-05-11 2018-03-31 13F FATE THERAPEUTICS COM 31189P102 10,298 5,105 98.31 100 212.50 0.0001
2018-02-12 2017-12-31 13F FATE THERAPEUTICS COM 31189P102 5,193 5,123 7,318.57 32 0.0000
2017-11-13 2017-09-30 13F FATE THERAPEUTICS COM 31189P102 70 -27 -27.84 0 0.0000
2017-08-11 2017-06-30 13F FATE THERAPEUTICS COM 31189P102 97 -3 -3.00 0 0.0000
2017-05-12 2017-03-31 13F FATE THERAPEUTICS COM 31189P102 100 100 0 0.0000
2016-08-12 2016-06-30 13F FATE THERAPEUTICS COM 31189P102 0 -13 -100.00 0 0.0000
2016-05-13 2016-03-31 13F FATE THERAPEUTICS COM 31189P102 13 13 0.00 0 0.0000
2015-11-13 2015-09-30 13F FATE THERAPEUTICS COM 31189P102 0 -84 -100.00 0 -100.00
2015-08-13 2015-06-30 13F FATE THERAPEUTICS COM 31189P102 84 84 0.00 1 0.0000
2015-02-17 2014-12-31 13F FATE THERAPEUTICS COM 31189P102 0 -395 -100.00 0 -100.00
2014-11-14 2014-09-30 13F FATE THERAPEUTICS COM 31189P102 395 348 740.43 2 0.0000
2014-02-14 2013-12-31 13F FATE THERAPEUTICS COM 31189P102 47 47 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.